RE: Who are the fools?24 Aug 2020 11:55
I’ll give you some reasons, 1) we allocated £4m in April for the order/manufacture of the drug (no mention of this), 2) since when did pharma’s valuations depend on imminent sales? 3) COPD and 4) the article assumes we are going it alone (this is very unlikely)